drugset / Trial / NCT01703832

Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects

NCT01703832 ↗

Phase 1/2 Completed 65 enrolled Biologische Heilmittel Heel GmbH
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to explore the efficacy of acutely dosed Neurexan using an experimental stress test called the Trier Social Stress Test

Timeline

Start
2012-10
Primary completion
2013-04
Completion
2013-04

Outcome

Missed primary endpoint

registry Neurexan® vs No Intervention; p = 0.1233; ANCOVA NCT01703832 ↗

registry Neurexan® vs No Intervention; p = 0.5153; ANCOVA NCT01703832 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neurexan Unknown 0.6 mg —

Indications